Molecular epidemiology of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1114-1120

  Peirano, Gisele ^a,b   Hung King Sang, Jessica ^a   Pitondo silva, André ^c   Laupland, Kevin B ^b,d   Pitout, Johann D D ^a,b  

^a CALGARY LABORATORY SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

ESBLs; MLST; Population based surveillance

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COUNT; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; GENETIC SIMILARITY; HUMAN; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CANADA; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84859600278     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks026     Document Type: Article

References (33)

1. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
2. Talbot GH, Bradley J, Edwards JE Jr et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42: 657-68.
3. Knothe H, Shah P, Krcmery V et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-7.
4. Quinn JP, Miyashiro D, Sahm D et al. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33: 1451-6.
5. Reinert RR, Low DE, Rossi F et al. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 2007; 60: 1018-29.
6. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-66.
7. Robicsek A, Strahilevitz J, Jacoby GA et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006; 12: 83-8.
8. Pitout JD, Hanson ND, Church DL et al. Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum β-lactamases: importance of community isolates with blaCTX-M genes. Clin Infect Dis 2004; 38: 1736-41.
9. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
11. Pitout JD, Church DL, Gregson DB et al. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 2007; 51: 1281-6.
12. Robicsek A, Strahilevitz J, Sahm DF et al. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006; 50: 2872-4.
13. Park CH, Robicsek A, Jacoby GA et al. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3953-5.
14. Yamane K, Wachino J, Suzuki S et al. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008; 52: 1564-6.
15. Hunter SB, Vauterin P, Lambert-Fair MA et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005; 43: 1045-50.
16. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
17. Diancourt L, Passet V, Verhoef J et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-82.
18. Zhanel GG, DeCorby M, Adam H et al. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrob Agents Chemother 2010; 54: 4684-93.
19. Karlowsky JA, Lagace-Wiens PR, Simner PJ et al. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 2011; 55: 3169-75.
20. Adam HJ, DeCorby M, Rennie R et al. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011; 69: 307-13.
21. Pitout JD, Gregson DB, Campbell L et al. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009; 53: 2846-51.
22. Peirano G, van der Bij AK, Gregson DB et al. Molecular epidemiology over an eleven-year period (2000-10) of extended-spectrum β-lactamaseproducing Escherichia coli causing bacteraemia in a centralized Canadian region. J Clin Microbiol 2012; 50: 294-9.
23. Paterson DL, Hujer KM, Hujer AM et al. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 2003; 47: 3554-60.
24. Coelho A, Mirelis B, Alonso-Tarres C et al. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain. J Antimicrob Chemother 2009; 64: 862-4.
25. Lytsy B, Sandegren L, Tano E et al. The first major extended-spectrum β-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008; 116: 302-8.
26. Muzaheed, Doi Y, Adams-Haduch JM et al. High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 2008; 61: 1393-4.
27. Lee MY, Ko KS, Kang CI et al. High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 2011; 38: 160-3.
28. Pitout JD, Wei Y, Church DL et al. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr. J Antimicrob Chemother 2008; 61: 999-1002.
29. Sullivan CB, Diggle MA, Clarke SC. Multilocus sequence typing: data analysis in clinical microbiology and public health. Mol Biotechnol 2005; 29: 245-54.
30. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-21.
31. Oteo J, Cuevas O, Lopez-Rodriguez I et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother 2009; 64: 524-8.
32. Ruiz de Alegria C, Rodriguez-Bano J, Cano ME et al. Klebsiella pneumoniae strains producing extended-spectrum β-lactamases in Spain: microbiological and clinical features. J Clin Microbiol 2011; 49: 1134-6.
33. Chong Y, Yakushiji H, Ito Y et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 2011; 30: 83-7.